Diabetes-Associated Residual Risk in Statin-Treated Patients with Atherosclerotic Cardiovascular Disease

被引：0
|
作者：
Wong, Nathan D.
Zhao, Yanglu
Xiang, Pin
Antonio, J.
Lopez, G.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1462-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1462-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease
    Zhao, Yanglu
    Xiang, Pin
    Coll, Blai
    Lopez, J. Antonio G.
    Wong, Nathan D.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (03)
  • [2] Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
    Sirimarco, G.
    Labreuche, J.
    Bruckert, E.
    Goldstein, L. B.
    Fox, K. M.
    Rothwell, P. M.
    Amarenco, P.
    [J]. CEREBROVASCULAR DISEASES, 2014, 37 : 90 - 90
  • [3] Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
    Sirimarco, Gaia
    Labreuche, Julien
    Bruckert, Eric
    Goldstein, Larry B.
    Fox, Kim M.
    Rothwell, Peter M.
    Amarenco, Pierre
    [J]. STROKE, 2014, 45 (05) : 1429 - 1436
  • [4] Lipoprotein(a) is a Determinant of Residual Cardiovascular Risk in the Setting of Optimal LDL-C in Statin-Treated Patients With Atherosclerotic Cardiovascular Disease
    Ruotolo, Giacomo
    Lincoff, Michael A.
    Menon, Venu
    McErlean, Ellen
    Wolski, Kathy
    Haas, Joseph V.
    Weerakkody, Govinda
    Riesmeyer, Jeffrey S.
    Nissen, Steven E.
    Nicholls, Stephen J.
    [J]. CIRCULATION, 2017, 136
  • [5] Lipoprotein(a)-Associated Residual Atherosclerotic Cardiovascular Disease Risk in Patients with Cardiovascular Disease on Statin Therapy by Diabetes Status
    Zhao, Yanglu
    Sung, Jennifer C.
    Browne, Auris
    Wong, Nathan D.
    [J]. DIABETES, 2020, 69
  • [6] Residual atherosclerotic cardiovascular disease risk in statin-treated adults: the multi-ethnic study of atherosclerosis
    Wong, N. D.
    Zhao, Y.
    Quek, R. G. W.
    Blumenthal, R. S.
    Budoff, M. J.
    Cushman, M.
    Garg, P.
    Sandfort, V.
    Tsai, M.
    Lopez, J. A.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1014 - 1014
  • [7] Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis
    Wong, Nathan D.
    Zhao, Yanglu
    Quek, Ruben G. W.
    Blumenthal, Roger S.
    Budoff, Matthew J.
    Cushman, Mary
    Garg, Parveen
    Sandfort, Veit
    Tsai, Michael
    Lopez, J. Antonio G.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (05) : 1223 - 1233
  • [8] Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update
    Reiner, Z.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2013, 23 (09) : 799 - 807
  • [9] Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging Drugs
    Kohei Takata
    Stephen J. Nicholls
    [J]. American Journal of Cardiovascular Drugs, 2019, 19 : 113 - 131
  • [10] Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging Drugs
    Takata, Kohei
    Nicholls, Stephen J.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (02) : 113 - 131
12345